Global Longlife Hospital and Research Ltd
₹ 12.6
-0.87%
23 Oct
- close price
About
Incorporated in 2015, Global Longlife Hospital & Research Ltd is in the business of Health Care and Hospitals[1]
Key Points
- Market Cap ₹ 13.2 Cr.
- Current Price ₹ 12.6
- High / Low ₹ 25.8 / 9.00
- Stock P/E
- Book Value ₹ 22.6
- Dividend Yield 0.00 %
- ROCE -3.92 %
- ROE -6.81 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.56 times its book value
Cons
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -22.9%
- Promoter holding is low: 0.02%
- Company has a low return on equity of -8.85% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 33.44 | 33.32 | 32.70 | 32.44 | 23.38 | 13.46 | 0.31 | -0.00 | |
| 26.61 | 29.88 | 27.26 | 24.14 | 19.30 | 13.68 | 4.45 | 1.00 | |
| Operating Profit | 6.83 | 3.44 | 5.44 | 8.30 | 4.08 | -0.22 | -4.14 | -1.00 |
| OPM % | 20.42% | 10.32% | 16.64% | 25.59% | 17.45% | -1.63% | -1,335.48% | |
| 0.08 | 0.03 | 0.06 | 0.17 | 0.24 | -0.00 | 5.02 | 0.01 | |
| Interest | 2.07 | 2.41 | 2.44 | 1.62 | 0.45 | 0.80 | 0.30 | -0.00 |
| Depreciation | 2.15 | 2.13 | 1.31 | 1.14 | 1.17 | 1.25 | 0.48 | -0.00 |
| Profit before tax | 2.69 | -1.07 | 1.75 | 5.71 | 2.70 | -2.27 | 0.10 | -0.99 |
| Tax % | 49.07% | -18.69% | -16.57% | 37.30% | 32.59% | -3.52% | -100.00% | 73.74% |
| 1.36 | -0.86 | 2.05 | 3.57 | 1.83 | -2.19 | 0.20 | -1.72 | |
| EPS in Rs | 1.94 | -1.23 | 2.93 | 5.10 | 1.74 | -2.09 | 0.19 | -1.64 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 63% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -34% |
| 1 Year: | -44% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -2% |
| 3 Years: | -9% |
| Last Year: | -7% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.00 | 7.00 | 7.00 | 7.00 | 10.50 | 10.50 | 10.50 | 10.50 |
| Reserves | 5.35 | 4.49 | 6.68 | 9.96 | 53.79 | 15.43 | 16.29 | 13.25 |
| 27.18 | 23.51 | 17.04 | 8.69 | 9.29 | 12.74 | -0.00 | -0.00 | |
| 3.77 | 6.92 | 6.06 | 8.33 | 2.36 | 3.07 | 0.06 | 0.01 | |
| Total Liabilities | 43.30 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |
| 20.17 | 18.72 | 17.46 | 16.71 | 16.52 | 17.27 | -0.00 | -0.00 | |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | 1.03 | -0.00 | -0.00 | -0.00 |
| Investments | 0.10 | 0.10 | 0.47 | 0.10 | 0.10 | 0.03 | 0.03 | -0.00 |
| 23.03 | 23.10 | 18.85 | 17.17 | 58.29 | 24.44 | 26.82 | 23.76 | |
| Total Assets | 43.30 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 5.40 | 3.90 | 6.88 | 9.42 | -40.42 | -5.07 | 12.32 | -4.51 | |
| -0.33 | -0.04 | 0.02 | 0.01 | -1.90 | -0.82 | 21.80 | 0.04 | |
| -4.77 | -3.05 | -7.22 | -9.66 | 45.70 | 2.67 | -13.01 | -0.00 | |
| Net Cash Flow | 0.31 | 0.81 | -0.33 | -0.22 | 3.38 | -3.22 | 21.11 | -4.47 |
| Free Cash Flow | 5.00 | 3.79 | 6.84 | 8.96 | -42.42 | -6.10 | 33.42 | -4.51 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 79% | 113% | 126% | 105% | -960% | 2,259% | -304% | 401% |
Ratios
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94.85 | 68.68 | 87.51 | 100.25 | 151.43 | 52.88 | 376.77 | |
| Inventory Days | 169.49 | 157.97 | 34.46 | 88.98 | 69.12 | 131.64 | -0.00 | |
| Days Payable | 229.91 | 391.69 | 138.68 | 432.74 | 110.43 | 765.90 | ||
| Cash Conversion Cycle | 34.44 | -165.03 | -16.71 | -243.52 | 110.13 | -581.38 | 376.77 | |
| Working Capital Days | 19.21 | 12.16 | 7.14 | -29.70 | 344.86 | -238.36 | 1,283.39 | |
| ROCE % | 3.81% | 12.75% | 26.22% | 6.35% | -2.51% | -13.69% | -3.92% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| NABH Accreditation Status Binary (1=Accredited) |
|
||||
| Total Employees Number |
|||||
| Solar Power Plant Capacity KW (DC) |
|||||
| Total Bed Capacity Beds |
|||||
| Sale of Products Share of Revenue % of Revenue from Operations |
|||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Publication of Newspaper Advertisement of Notice of First Extra Ordinary General Meeting and E Voting Information.
-
Notice Of First Extra Ordinary General Meeting Of The Company For FY 2026-2027 To Be Held On Friday, October 30, 2026 At 12:15 P.M. IST Through Video Conferencing (VC) And Other Audio Visual Means (OAVM).
- EGM on Oct 30, 2026 to ratify CA certificate for Asahi Enterprise name change.
-
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Asahi Enterprise Limited (Formerly Known As Global Longlife Hospital And Research Limited) Held Today I.E. Saturday, October 03, At 02:15 P.M.
- Board approved EGM on October 30, 2026 to seek shareholder approval for an issuance.
- Closure of Trading Window
-
Intimation Regarding Alteration In Name Of The Company Pursuant To Approval Of Registrar Of Companies
- ROC approved name change to Asahi Enterprise Limited on September 25, 2026.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
Business Overview[1]
The company operates a multi-specialty tertiary care hospital in Gujarat, providing infrastructure and clinical support for a broad range of medical and surgical specialties. It follows an open-doctor model, allowing qualified doctors with 3+ years of experience to admit and treat patients at the hospital.